Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4B |
| 2 |
TC Energy
TRP
|
+$1.99B |
| 3 |
Amazon
AMZN
|
+$1.97B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.83B |
| 5 |
NVIDIA
NVDA
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.57B |
| 2 |
Scotiabank
BNS
|
+$1.51B |
| 3 |
Enbridge
ENB
|
+$1.47B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.02B |
| 5 |
Medtronic
MDT
|
+$871M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 9.2% |
| 3 | Consumer Discretionary | 8.28% |
| 4 | Communication Services | 6.4% |
| 5 | Healthcare | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
Mesa Laboratories
MLAB
$574M
| $2.8M | ﹤0.01% |
41,781
+12,355
| +42% | +$889K |
|
4152
OptimizeRx
OPRX
$133M
| $2.8M | ﹤0.01% |
136,464
+87,518
| +179% | +$1.39M |
|
4153
Citi Trends
CTRN
$605M
| $2.79M | ﹤0.01% |
89,993
+26,031
| +41% | +$842K |
|
4154
F&G Annuities & Life
FG
$3.62B
| $2.79M | ﹤0.01% |
89,129
-8,566
| -9% | -$283K |
|
4155
Zai Lab
ZLAB
$2.62B
| $2.79M | ﹤0.01% |
82,181
-62,141
| -43% | -$2.14M |
|
4156
Calumet Specialty Products
CLMT
$3.44B
| $2.78M | ﹤0.01% |
152,488
+18,775
| +14% | +$309K |
|
4157
PUT
Futu Holdings
FUTU
$15.3B
| $2.78M | ﹤0.01% |
16,000
-85,500
| -84% | -$14.2M |
|
4158
PUT
Xcel Energy
XEL
$48.8B
| $2.78M | ﹤0.01% |
+34,500
| New | +$2.5M |
|
4159
iShares iBonds Dec 2028 Term Treasury ETF
IBTI
$1.92B
| $2.78M | ﹤0.01% |
124,256
-144,265
| -54% | -$3.22M |
|
4160
PUT
ZTO Express
ZTO
$17.9B
| $2.78M | ﹤0.01% |
144,700
-463,700
| -76% | -$8.88M |
|
4161
T. Rowe Price Growth ETF
TGRT
$1.56B
| $2.78M | ﹤0.01% |
+63,619
| New | +$2.66M |
|
4162
iShares Morningstar Small-Cap ETF
ISCB
$292M
| $2.77M | ﹤0.01% |
43,648
| – | – |
|
4163
PUT
Las Vegas Sands
LVS
$29.6B
| $2.76M | ﹤0.01% |
51,300
-73,700
| -59% | -$3.88M |
|
4164
PUT
Warner Bros
WBD
$67.1B
| $2.75M | ﹤0.01% |
141,000
-929,000
| -87% | -$12.7M |
|
4165
iShares Russell Top 200 Value ETF
IWX
$4.07B
| $2.75M | ﹤0.01% |
31,273
+15,689
| +101% | +$1.35M |
|
4166
Marcus & Millichap
MMI
$1.19B
| $2.75M | ﹤0.01% |
93,576
+4,646
| +5% | +$146K |
|
|
CAFX
4167
Congress Intermediate Bond ETF
CAFX
$321M
| $2.75M | ﹤0.01% |
+109,757
| New | +$2.74M |
|
|
SLMT
4168
Brera Holdings
SLMT
$44.5M
| $2.74M | ﹤0.01% |
+9,129
| New | +$840K |
|
|
JMIA
4169
CALL
Jumia Technologies
JMIA
$767M
| $2.74M | ﹤0.01% |
+235,800
| New | +$1.72M |
|
4170
Invesco Bloomberg Pricing Power ETF
POWA
$183M
| $2.74M | ﹤0.01% |
30,219
+6,669
| +28% | +$593K |
|
4171
Benitec Biopharma
BNTC
$468M
| $2.73M | ﹤0.01% |
194,363
+173,369
| +826% | +$2.21M |
|
4172
PUT
Edwards Lifesciences
EW
$51.7B
| $2.72M | ﹤0.01% |
35,000
| – | – |
|
|
CTO
4173
CTO Realty Growth
CTO
$815M
| $2.72M | ﹤0.01% |
166,827
+40,047
| +32% | +$676K |
|
|
CNL
4174
Collective Mining Ltd
CNL
$1.31B
| $2.72M | ﹤0.01% |
188,018
+13,819
| +8% | +$157K |
|
4175
Kopin
KOPN
$791M
| $2.71M | ﹤0.01% |
1,117,215
+1,042,138
| +1,388% | +$2.13M |
|
Similar funds
Goldman Sachs's Q3 2025 Portfolio in Review
As of Q3 2025, Goldman Sachs held 6,765 positions worth $817B, up 11% from $736B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Goldman Sachs's Q3 2025 filing shows 707 new, 2,950 increased, 2,106 reduced and 470 closed positions. Its largest new stake was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M. The largest sale was iShares Russell 2000 ETF, an estimated $1.57B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q3 2025 buy was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M.
- Goldman Sachs added most to Microsoft in Q3 2025, an estimated $4B increase.
- Goldman Sachs's biggest Q3 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $1.57B.
- Goldman Sachs fully exited Ansys in Q3 2025, selling an estimated $564M.
- Goldman Sachs's ten largest holdings make up 22% of its $817B portfolio in Q3 2025.
- Goldman Sachs opened 707 new positions and closed 470 in Q3 2025.
- Goldman Sachs's portfolio value rose 11% quarter-over-quarter to $817B.
Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.